News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
399 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26635)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
2 (18)
3 (192)
4 (399)
5 (344)
6 (307)
7 (143)
8 (3)
9 (40)
10 (389)
11 (192)
12 (199)
13 (188)
14 (96)
15 (3)
16 (29)
17 (74)
18 (340)
19 (185)
20 (212)
21 (85)
22 (1)
23 (15)
24 (197)
25 (192)
26 (163)
27 (186)
28 (91)
29 (1)
30 (4)
31 (163)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
OrphoMed, Inc. Announces Positive Phase 2 Results for ORP-101 100 mg Once-Daily Dose in IBS-D Patients
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, today announced positive results from the recent Phase 2 study of ORP-101 for treatment of irritable bowel syndrome with diarrhea (IBS-D).
January 4, 2022
·
6 min read
BioMidwest
Viveve to Participate in H.C. Wainwright BIOCONNECT Conference
Viveve Medical, Inc., a medical technology company focused on women’s health, announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright BIOCONNECT Conference, January 10 - 13, 2022.
January 4, 2022
·
3 min read
Biotech Beach
Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 40th annual J.P. Morgan Healthcare Conference on January 10, 2022.
January 4, 2022
·
1 min read
Biotech Bay
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices
Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a partnership with Illumina, Inc., aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.
January 4, 2022
·
2 min read
Business
Genmab and Synaffix Enter into License Agreement for ADC Technology
Genmab A/S (Nasdaq: GMAB) and Synaffix B.V., announced today that Genmab and Synaffix have signed a license agreement providing Genmab broad access to Synaffix’s ADC technologies.
January 4, 2022
·
6 min read
BioCapital
Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference
Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference.
January 4, 2022
·
1 min read
Genetown
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2021 Results
Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022.
January 4, 2022
·
1 min read
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells
PharmaCyte Biotech, Inc. (NASDAQ: PMCB), today announced that the empty capsule material that makes up PharmaCyte’s CypCaps® pancreatic cancer product candidate is not toxic for the encapsulated cells inside the CypCaps.
January 4, 2022
·
4 min read
ModivCare to Participate in Upcoming Investor Conferences
ModivCare Inc. today announced that Dan Greenleaf, President and Chief Executive Officer, and Heath Sampson, Chief Financial Officer, are scheduled to present at the following upcoming investor conference.
January 4, 2022
·
1 min read
Biotech Beach
Apollo Medical Holdings, Inc. to Present at 40th Annual J.P. Morgan Healthcare Conference
Apollo Medical Holdings, Inc. today announced that Brandon Sim , Co-Chief Executive Officer, is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10:30 a.m. PT/1:30 p.m. ET.
January 4, 2022
·
1 min read
Previous
29 of 40
Next